Follow the 씨젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 씨젠 has logged 1 public disclosures. Market capitalisation: €1,187bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 씨젠. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
씨젠 is a company specialized in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing molecular diagnostic solutions.